Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Booster Compressors
... at a CAGR of 5.3% over the analysis period 2023-2030. Air Cooling, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024(Status and Outlook)
... risk of developing TB. The Global BCG Vaccine for Tuberculosis (TB) Market Size was estimated at USD 397.17 million in 2023 and is projected to reach USD 550.75 million by 2029, exhibiting a CAGR of ... Read More
-
Axial Spondyloarthritis - Market Insight, Epidemiology And Market Forecast - 2034
... disorder characterized by a range of challenging symptoms, including hyperphagia (excessive hunger), obesity, and behavioral issues. PWS is often misdiagnosed in neonates because of its nonspecific clinical manifestations. Definitive molecular genetic testing should be readily ... Read More
-
Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges), By Application (Pain Management, Smoking Cessation, Angina Pectoris), By End-use, By Region, And Segment Forecast, 2024 - 2030
... Buccal Drug Delivery Systems Market Growth & Trends The global buccal drug delivery systems market size is expected to reach USD 6.56 billion by 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032
... US$ 584.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 879.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032. Dengue, also known as breakbone fever, is ... Read More
-
France Diabetes Market Report: 2024-2032
... of 5.33% during 2024-2032. IMARC’s new report “France Diabetes Market Report: 2024-2032” provides an analytical and statistical insight into the France diabetes market. The report provides both current and future trends in the prevalence, demographical ... Read More
-
Tuberculosis Diagnostics Market Report by Disease Stage (Latent TB, Active TB), Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, and Others), End-User (Hospitals and Clinics, Diagnostics and Research Laboratories, and Others), and Region 2024-2032
... Laboratories, and Others), and Region 2024-2032 The global tuberculosis diagnostics market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth ... Read More
-
Neurostimulation Devices Market Report by Stimulation Type (Internal Stimulation, External Stimulation), Device Type (SCS (Spinal Cord Stimulation) Devices, DBS (Deep Brain Stimulation) Devices, SNS (Sacral Nerve Stimulation) Devices, VNS (Vagus Nerve Stimulation) Devices, GES (Gastric Electrical Stimulation) Devices, Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, and Others), Application (Pain Management, Epilepsy, Essential Tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Parkinson’s Disease, and Others), End-User (Rehabilitation Centers, Hospitals, Medical Clinics, and Others), and Region 2024-2032
... Electrical Stimulation) Devices, Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, and Others), Application (Pain Management, Epilepsy, Essential Tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Parkinson’s Disease, and Others), End-User (Rehabilitation Centers, Hospitals, Medical ... Read More
-
Neuromodulation Market Report by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Others), and Region 2024-2032
... US$ 7.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The market is experiencing robust growth, driven ... Read More
-
Global Deep Brain Stimulation Market: Analysis By Product (Dual Channel and Single Channel), By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy and Others), By End Use (Hospitals, Neurology Clinics, Ambulatory Surgical Clinics and Research Centers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2023 Base Year 2023 Forecast Period 2024-2029 Page Count 153 Units Referenced US ... Read More
-
Global Endothelial Dysfunction Market: Analysis By Test Type (Invasive Tests and Non-Invasive Tests), By Cause (Hypertension, Diabetes, Hypercholestrolaemia, Behcet’s Disease, Obesity, and Others), By End-User (Hospitals, Diagnostics Centers, Clinics, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 163 Units Referenced US $ Segments/Key Topics By ... Read More
-
Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update"" provides comprehensive information about the Diabetes Assays ... Read More
-
Global Anti Epilepsy Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 4130.1 million by 2030 with a CAGR of 2.0% during review period. Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, ... Read More
-
Alzheimer’s Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostics Technique (Biomarkers, Imaging Techniques), By Type (Triage, Diagnosis), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2
... Diagnostics Market Growth & Trends The global Alzheimer’s disease diagnostics market size is expected to reach USD 15.92 billion by 2030, registering a CAGR of 11.4% from 2024 to 2030, according to a new report ... Read More
-
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
... trends within In Vitro Diagnostics therapeutic area. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. SARS-CoV-2 is a positive-sense ... Read More
-
Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029
... an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period. Due to rapid growth in the senior population, the ... Read More
-
Soft Tissue Sarcoma: Competitive Landscape
... prevalent cases of STS are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for STS. Currently, the market space for STS holds many innovator drugs. Prominent companies such as Roche, BMS, Novartis, and ... Read More
-
Europe Hemoglobinopathies Market Report and Forecast 2024-2032
... significant market share. It is driven by the rising prevalence of thalassemia and sickle cell anemia. The global market is expected to grow at a CAGR of 5.1% during the forecast period of 2024-2032, with ... Read More
-
Europe In-Vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032
... screening tests market size was valued at USD 920.4 million in 2023, with Europe holding a significant market share. The market is driven by the rising prevalence of colorectal cancer across the region. It is ... Read More
-
Global Dengue Rapid Test Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Dengue Rapid Test is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Building Insulation Market (by Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... progressing at a CAGR of 5.45% for the period spanning 2024-2028. Factors such as expanding building & construction industry, increasing emphasis on controlling greenhouse emissions, rising urbanization, growing focus on energy conservation and supportive government ... Read More
-
China Online Healthcare Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... spanning from 2024 to 2028. Growth in China online healthcare market is supported by factors such as aging population, rising health expenditure, support from Chinese government, technical innovations and rising internet penetration. However, the market ... Read More
-
Global Ebola Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Ebola viral infection was first observed in The Democratic Republic of Congo (named after a ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... 2024-2028. While, the TMV market in China is forecasted to reach US$4515.5 million in 2028, rising at a CAGR of 146.50%, for the time period of 2024-2028. Factors such as growing prevalence of aortic stenosis, ... Read More
Research Assistance
